← Leaderboards
Anthony V Nicola
Virginia Commonwealth University
$4,263,993
Attributed
$4,263,993
Total exposure
9
Grants
9
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $599.9K · FY2005–25$1M$750K$500K$250K$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$4,263,993 · 9
By mechanism
R01$1,963,894 · 1
R21$1,208,773 · 3
R03$455,000 · 3
R56$373,977 · 1
K22$262,349 · 1
Top collaborators
No co-investigators on record.
Others in their field
Top investigators on “Latent Infection”
- Constance Ann Benson · University Of California, San Diego$159,350,550
- David M. Margolis · University Of Texas Sw Med Ctr/Dallas$81,708,013
- Alice Telesnitsky · University Of Michigan At Ann Arbor$48,806,043
- Rafick-Pierre Sekaly · University Of Montreal$42,824,227
- Robert Turner Schooley · University Of Colorado Denver$42,307,156
- Melanie Maria Ott · J. David Gladstone Institutes$30,834,800
Research focus
Latent InfectionHerpes LabialisInfectionVirusViralSimplexvirusCellsEncephalitisBlindnessPathogenMorbidity - Disease RateEpithelial CellsNovel StrategiesSexually Transmitted DiseasesGenital InfectionMolecularPreventProteinsExperimental DesignsBiochemistryMembrane FusionHerpesviridae InfectionsCellular BiologyHerpesviridae
Grant awards (22)
Membrane sphingomyelin and HSV entry$185,513
R21 · FY2025 · AI · contact PI
The Golgi complex and HSV entry$76,500
R03 · FY2025 · AI · contact PI
Membrane sphingomyelin and HSV entry$229,500
R21 · FY2024 · AI · contact PI
The Golgi complex and HSV entry$76,500
R03 · FY2024 · AI · contact PI
Viral and cellular mechanisms of HSV fusion and entry$373,977
R56 · FY2022 · AI · contact PI
Low pH-mediated HSV fusion and entry$377,500
R01 · FY2019 · AI · contact PI
Low pH-mediated HSV fusion and entry$377,500
R01 · FY2018 · AI · contact PI
Low pH-mediated HSV fusion and entry$382,456
R01 · FY2017 · AI · contact PI
ROLE OF HSV gK IN EPITHELIAL CELL ENTRY$75,500
R03 · FY2017 · AI · contact PI
Low pH-mediated HSV fusion and entry$377,500
R01 · FY2016 · AI · contact PI
ROLE OF HSV gK IN EPITHELIAL CELL ENTRY$75,500
R03 · FY2016 · AI · contact PI
BLOCKING HSV INFECTION WITH BORTEZOMIB$75,500
R03 · FY2016 · AI · contact PI
Low pH-mediated HSV fusion and entry$71,438
R01 · FY2016 · AI · contact PI
Low pH-mediated HSV fusion and entry$377,500
R01 · FY2015 · AI · contact PI
BLOCKING HSV INFECTION WITH BORTEZOMIB$75,500
R03 · FY2015 · AI · contact PI
Conformational change in HSV glycoprotein B$177,425
R21 · FY2013 · AI · contact PI
Conformational change in HSV glycoprotein B$217,126
R21 · FY2012 · AI · contact PI
Tegument ICP0 and HSV Entry$97,226
R21 · FY2010 · AI · contact PI
Tegument ICP0 and HSV Entry$83,349
R21 · FY2010 · AI · contact PI
Tegument ICP0 and HSV Entry$218,634
R21 · FY2009 · AI · contact PI
HERPES SIMPLEX VIRUS ENTRY VIA ENDOCYTOSIS$107,160
K22 · FY2006 · AI · contact PI
HERPES SIMPLEX VIRUS ENTRY VIA ENDOCYTOSIS$155,189
K22 · FY2005 · AI